Arctoris has established a broad range of remotely accessible COVID-19 assays, including biochemical profiling for COVID-19 drug targets, as well as cellular and molecular assays conducted in its state-of-the-art robotic facility.

New survey results show almost one-third of life science organizations polled are set to begin quantum computing evaluation this year.

Paige will use this new capital to further accelerate its mission in transforming pathology workflows in the field of cancer, while working closely with biopharma companies to create custom diagnostic and clinical trial solutions to improve patient care.

SCIEX has introduced the fully integrated SCIEX OS Software, the core engine running SCIEX innovations.

Aigenpulse has introduced a new state-of-the-art data intelligence platform that is designed to expedite the drug discovery and development process.

LabVantage has announced that the newly released 8.5 edition of its LabVantage platform offers a fully integrated Scientific Data Management System (SDMS, ensuring security and control against data loss or modification.

Freyr has announced the launch of a web platform for COVID-19 driven with real-time information for manufacturers to help them get to market and support them in emergency use authorizations with global regulatory authorities.

My Personal Therapeutics and Pentavere have announced their successful EUREKA Collaborative R&D: AI and Quantum Technologies Competition award for project titled "Utilisation of AI to develop Personalised Treatment Plans for cancer".

Dotmatics Ltd. has announced that it has entered into an agreement to acquire BioBright LLC, aiming to create a unique combination of lab data capture, data processing, electronic lab notebook (ELN) and data analytics capability from a single supplier.

Waters Corporation has announced a new fragmentation technique and an imaging option for its high-resolution mass spectrometers.